REQUEST A DEMO
Total
USD $0.00
Search more companies

Antah Pharma Sdn Bhd (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Antah Pharma Sdn Bhd Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Antah Pharma Sdn Bhd is an enterprise located in Malaysia, with the main office in Petaling Jaya. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on April 24, 1984. 200 (2023) employees currently work for Antah Pharma Sdn Bhd. In its most recent financial highlights, the company reported a net sales revenue increase of 44.19% in 2022. A growth of 6.4% was recorded in its total assets. Antah Pharma Sdn Bhd’s net profit margin increased by 0.34% in 2022.

Headquarters
1St Floor, No. 3, Jalan 19/1
Petaling Jaya; Selangor; Postal Code: 46300

Contact Details: Purchase the Antah Pharma Sdn Bhd report to view the information.

Website: http://www.ahcg.com.my

Basic Information
Total Employees:
Purchase the Antah Pharma Sdn Bhd report to view the information.
Outstanding Shares:
Purchase the Antah Pharma Sdn Bhd report to view the information.
Registered Capital:
Purchase the Antah Pharma Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Antah Pharma Sdn Bhd report to view the information.
Incorporation Date:
April 24, 1984
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Antah Pharma Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
44.19%
Total operating revenue
44.19%
Operating profit (EBIT)
270.28%
EBITDA
69.55%
Net Profit (Loss) for the Period
253.4%
Total assets
6.4%
Total equity
3.95%
Operating Profit Margin (ROS)
0.83%
Net Profit Margin
0.34%
Return on Equity (ROE)
2.68%
Debt to Equity Ratio
-8.42%
Quick Ratio
-0%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?